The present invention relates to novel compounds according to the general formulas I, II, III, IV or V:wherein B is nucleoside base according to the structure:and the remaining variables as defined in the specification, and pharmaceutical compositions comprising the compounds. The compounds are useful interalia as anti-viral agents in viral therapy.